for the 3-month period ended 31 March 2019 showed at Baht 52.9 million, increased from the same period of last year by Baht 6.3 million or 13.5%. Earnings per share is Baht 0.30 per share, increased

by GJS shareholders.3. The fair value of GJS share price of B0.26 per share calculated from market price, is B0.02 (8.33%) higher than the offering price. Therefore, the B0.24 per share offering price

- Translation- June 11, 2019 Subject: Notification the Acquisition of share of BS Myco Biotech Company Limited. (Additional Information Memorandum Concerning the Acquisition of Assets) To: Director and Manager

andum regard ers g Corporation n October 4, s follows: se to the Extra ed capital of B 09.00 by decre 907,153 share Association o ecutive Comm managing di of Association ry action to co se to the Extra d

Company Limited equivalent to 74,000,000 ordinary shares at the par value of Baht 10 per share, totaling transaction value of Baht 1,695 million 2. The meeting resolved to approve the authorization of

share capital1 (the “Share Purchase”), at the price of INR 36 per share, equaling to the total investment amount of INR 2,988.00 million (the “Maximum Share Purchase Cost”), or equivalent to approximately

, increased by 7.20% compared to last year. As a result, the Company reported net profit of Baht 65.98 million, decreased by 30.23% from last year. Earnings per share presented at Baht 3.09. Statement of

Plc. would like to inform the financial results for the third quarter of 2019 which ended on 30 September 2019. The Company and its subsidiary reported a net loss of THB 26. 14 million or loss per share

share. 2. Approved to propose to the Extraordinary General Meeting of Shareholders No .1 /2018 to consider and approve the amendment of Clause 4 of the Memorandum of Association of the Company to be in

registered capital of THB 217,155,228 to THB 180,970,466.50 by canceling the Company’s 144,739,046 authorized but unissued shares, with a par value of THB 0.25 per share. 2. Approved to propose to the